Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience (TWST)
:TWST
Earnings Data
Report Date
Jan 30, 2026After Close (Confirmed)
Period Ending
2026 (Q1)Consensus EPS Forecast
-0.43Last Year’s EPS
-0.53Same Quarter Last Year
Strong Buy
Based on 5 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
Twist Bioscience reported strong financial performance with record revenue and significant margin improvement, driven by growth in SynBio, Biopharma, and NGS segments. However, the transition of a major customer and moderate growth guidance for fiscal 2026 presents challenges. The company is optimistic about future growth driven by AI-enabled discovery and new product introductions.Company Guidance
Record Revenue Achievement
Twist Bioscience reported a record quarter with $99 million in revenue, exceeding guidance and marking a 17% year-over-year increase. For the fiscal year, revenue was $376.6 million, a growth of 20% over fiscal 2024.
Significant Gross Margin Improvement
Gross margin for the quarter was 51.3%, and for the year, it was 50.7%, up from 42.6% in fiscal 2024, marked by a nearly 20 margin points increase over the last two years.
Strong SynBio and Biopharma Growth
SynBio revenue was $39.5 million, up 17% year-over-year, driven by the Express portfolio. Biopharma revenue grew by 22% year-over-year to $6.4 million.
NGS Revenue Growth
NGS reported revenues of $53 million, representing a 16% year-over-year growth, driven by successful diagnostic customer assays.
AI-Enabled Discovery Growth
AI-enabled drug discovery projects grew more than $25 million versus fiscal 2024, highlighting significant growth potential in AI-driven drug discovery.
TWST Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TWST Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 14, 2025 | $29.90 | $26.87 | -10.13% |
Aug 04, 2025 | $33.68 | $30.21 | -10.30% |
May 05, 2025 | $39.24 | $35.93 | -8.44% |
Feb 03, 2025 | $52.37 | $52.75 | +0.73% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Twist Bioscience (TWST) report earnings?
Twist Bioscience (TWST) is schdueled to report earning on Jan 30, 2026, After Close (Confirmed).
What is Twist Bioscience (TWST) earnings time?
Twist Bioscience (TWST) earnings time is at Jan 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TWST EPS forecast?
TWST EPS forecast for the fiscal quarter 2026 (Q1) is -0.43.
